Cerebral is a technology company.
Cerebral offers online mental health care, including therapy and medication management, accessible in all 50 states.
Cerebral has raised $465.0M across 3 funding rounds.
Cerebral has raised $465.0M in total across 3 funding rounds.
Cerebral is a telehealth startup providing accessible online mental health care for conditions like anxiety, depression, ADHD, and insomnia.[1][2][4] It serves patients nationwide through a subscription model offering personalized therapy, medication management, and virtual consultations with over 600 licensed clinicians, integrating AI for matching and engagement while accepting major insurances to reduce costs.[1][2][3]
The platform solves barriers to mental health access by enabling asynchronous messaging, video appointments, home medication delivery, and ongoing plan adjustments based on patient feedback and progress, with tiers varying by care level.[1][3] Growth surged post-2019 founding, raising nearly $500 million in 2021 at a $4.8 billion valuation, partnering with figures like Simone Biles, and expanding AI-driven features amid rising telehealth demand.[2]
Founded in 2019, Cerebral emerged amid growing mental health awareness, accelerated by the COVID-19 pandemic's telemedicine boom, which enabled cross-state consultations and reduced no-show rates.[2] CEO David Mou leads the clinician-led company, emphasizing AI integration from early on for patient-clinician matching (e.g., by ethnicity or gender) and suicide detection via natural language processing.[2]
Key leaders include President Dr. Michael Boggs, a board-certified psychiatrist focused on evidence-based telemental health; Director of Behavioral Care Morgan Bartholomew, PhD, blending tech and clinical science; and Chief Experience Officer Alexandria Stried, formerly of Ellevest, driving product and marketing.[3] Pivotal traction came in 2021 with massive funding and Simone Biles joining as investor and chief impact officer after her public mental health advocacy.[2]
Cerebral rides the telehealth wave democratizing mental health amid chronic provider shortages, where demand outstrips supply—pandemic-era expansions allowed nationwide access and better outcomes measurement.[2] Timing aligns with AI advancements in healthcare; early adoption of generative AI for personalization and efficiency positions it ahead, potentially revolutionizing care by integrating patient data for tailored models.[2]
Market forces like insurance adoption, reduced stigma (amplified by advocates like Biles), and tech scalability favor growth, influencing the ecosystem by proving AI-clinician hybrids can scale quality care and lower costs.[1][2] It sets benchmarks for digital health platforms blending rigorous science with user-centric tech.
Cerebral's clinician-led AI integration positions it to expand beyond core conditions into broader behavioral health, leveraging outcome data for predictive care and workforce optimization.[2] Trends like AI documentation (70% time savings) and multimodal therapy will shape its path, potentially dominating as telehealth matures post-pandemic.[2]
Influence may evolve through partnerships and insurance depth, scaling impact while navigating regulations—watch for deeper AI ethics focus and outcome transparency to sustain its accessibility edge, fulfilling the promise of tech-driven mental health equity.[2][3]
Cerebral has raised $465.0M in total across 3 funding rounds.
Cerebral's investors include Access Industries, AirAngels, Oak HC/FT, SoftBank Investment Advisers, Bill Ackman, Paul Rios, Active Capital, Ascension Ventures, Drive Capital, Hyde Park Venture Partners, Khosla Ventures, Moonshots Capital.
Cerebral has raised $465.0M across 3 funding rounds. Most recently, it raised $300.0M Series C in December 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2021 | $300.0M Series C | Access Industries, AirAngels, Oak HC/FT, SoftBank Investment Advisers, Bill Ackman, Paul Rios | |
| Jun 1, 2021 | $130.0M Series B | Access Industries, Active Capital, AirAngels, Ascension Ventures, Drive Capital, Hyde Park Venture Partners, Khosla Ventures, Moonshots Capital, Oak HC/FT, SoftBank Investment Advisers, Tiger Global Management, Transformation Capital, Bill Ackman | |
| Oct 1, 2020 | $35.0M Series A | Active Capital, Ascension Ventures, Drive Capital, Hyde Park Venture Partners, Khosla Ventures, Moonshots Capital, Oak HC/FT, Tiger Global Management, Transformation Capital |